Btissame El Hassouni

20182019
If you made any changes in Pure these will be visible here soon.

Research Output 2018 2019

  • 9 Article
  • 3 Review article
  • 1 Comment/Letter to the editor
2019

A brief guide to performing pharmacological studies in vitro: Reflections from the EORTC-PAMM Course “Preclinical and Early-phase Clinical Pharmacology”

Capula, M., Corno, C., Hassouni, B. E. L., Petri, G. L. I., Aranđelović, S. & on Behalf of the EORTC PAMM Group, 1 Jan 2019, In : Anticancer Research. 39, 7, p. 3413-3418

Research output: Contribution to journalReview articleAcademicpeer-review

Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)-1H-indole Derivatives against Pancreatic Cancer Cells*

Li Petri, G., Cascioferro, S., el Hassouni, B., Carbone, D., Parrino, B., Cirrincione, G., Peters, G. J., Diana, P. & Giovannetti, E., 1 Jan 2019, In : Anticancer Research. 39, 7, p. 3615-3620

Research output: Contribution to journalArticleAcademicpeer-review

CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage

el Hassouni, B., Mantini, G., Immordino, B., Peters, G. J. & Giovannetti, E., 2019, In : Molecules. 24, 24

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Pharmacogenetics of treatments for pancreatic cancer

el Hassouni, B., Li Petri, G., Liu, D. S. K., Cascioferro, S., Parrino, B., Hassan, W., Diana, P., Ali, A., Frampton, A. E. & Giovannetti, E., 3 Jun 2019, In : Expert Opinion on Drug Metabolism and Toxicology. 15, 6, p. 437-447 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Role of c-MET inhibitors in overcoming drug resistance in spheroid models of primary human pancreatic cancer and stellate cells

Firuzi, O., Che, P. P., el Hassouni, B., Buijs, M., Coppola, S., Löhr, M., Funel, N., Heuchel, R., Carnevale, I., Schmidt, T., Mantini, G., Avan, A., Saso, L., Peters, G. J. & Giovannetti, E., 1 May 2019, In : Cancers. 11, 5, 638.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

RX-3117 (fluorocyclopentenyl cytosine): a novel specific antimetabolite for selective cancer treatment

Balboni, B., el Hassouni, B., Honeywell, R. J., Sarkisjan, D., Giovannetti, E., Poore, J., Heaton, C., Peterson, C., Benaim, E., Lee, Y. B., Kim, D. J. & Peters, G. J., 3 Apr 2019, In : Expert Opinion on Investigational Drugs. 28, 4, p. 311-322 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma

Sciarrillo, R., Wojtuszkiewicz, A., El Hassouni, B., Funel, N., Gandellini, P., Lagerweij, T., Buonamici, S., Blijlevens, M., Zeeuw van der Laan, E. A., Zaffaroni, N., Deraco, M., Kusamura, S., Würdinger, T., Peters, G. J., Molthoff, C. F. M., Jansen, G., Kaspers, G. J. L., Cloos, J. & Giovannetti, E., Jan 2019, In : EBioMedicine. 39, p. 215-225

Research output: Contribution to journalArticleAcademicpeer-review

Targeting the Ribosome Biogenesis Key Molecule Fibrillarin to Avoid Chemoresistance

el Hassouni, B., Sarkisjan, D., Vos, J. C., Giovannetti, E. & Peters, G. J., 2019, In : Current Medicinal Chemistry. 26, 33, p. 6020-6032

Research output: Contribution to journalArticleAcademicpeer-review

The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies

el Hassouni, B., Granchi, C., Vallés-Martí, A., Supadmanaba, I. G. P., Bononi, G., Tuccinardi, T., Funel, N., Jimenez, C. R., Peters, G. J., Giovannetti, E. & Minutolo, F., 1 Jan 2019, In : Seminars in Cancer Biology.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology

El Hassouni, B., Mantini, G., Li Petri, G., Capula, M., Boyd, L., Weinstein, H. N. W., Vallés-Marti, A., Kouwenhoven, M. C. M., Giovannetti, E., Westerman, B. A., Peters, G. J. & EORTC PAMM Group, 1 Jan 2019, In : Anticancer Research. 39, 7, p. 3303-3309 7 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Uridine cytidine kinase 2 as a potential biomarker for treatment with RX-3117 in pancreatic cancer*

Hassouni, B. E. L., Infante, J., Mantini, G., Ricci, C., Funel, N., Giovannetti, E. & Peters, G. J., 1 Jan 2019, In : Anticancer Research. 39, 7, p. 3609-3614 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
2018

Multidrug-resistant transporter expression does not always result in drug resistance

le Large, T. Y. S., el Hassouni, B., Kazemier, G., Piersma, S. R., van Laarhoven, H. W. M., Bijlsma, M. F., Jimenez, C. R. & Giovannetti, E., 2018, In : Cancer Science. 109, 10, p. 3360-3362 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

Open Access